KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Change in Acquisitions & Divestments: 2015-2025

Historic Change in Acquisitions & Divestments for Idexx Laboratories (IDXX) over the last 5 years, with Sep 2025 value amounting to $349,000.

  • Idexx Laboratories' Change in Acquisitions & Divestments fell 15.90% to $349,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year decrease of 49.28%. This contributed to the annual value of $1.6 million for FY2024, which is 81.40% down from last year.
  • Per Idexx Laboratories' latest filing, its Change in Acquisitions & Divestments stood at $349,000 for Q3 2025, which was down 26.37% from $474,000 recorded in Q2 2025.
  • In the past 5 years, Idexx Laboratories' Change in Acquisitions & Divestments registered a high of $6.3 million during Q3 2023, and its lowest value of $329,000 during Q1 2024.
  • Over the past 3 years, Idexx Laboratories' median Change in Acquisitions & Divestments value was $416,000 (recorded in 2025), while the average stood at $1.2 million.
  • Per our database at Business Quant, Idexx Laboratories' Change in Acquisitions & Divestments slumped by 93.37% in 2024 and then rose by 26.44% in 2025.
  • Over the past 3 years, Idexx Laboratories' Change in Acquisitions & Divestments (Quarterly) stood at $2.1 million in 2023, then crashed by 80.39% to $416,000 in 2024, then dropped by 15.90% to $349,000 in 2025.
  • Its Change in Acquisitions & Divestments stands at $349,000 for Q3 2025, versus $474,000 for Q2 2025 and $416,000 for Q1 2025.